Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A national registry-based study.
Khodaie F, Moghadasi AN, Hosseinnataj A, Baghbanian SM, Ashtari F, Razazian N, Poursadeghfard M, Majdi-Nasab N, Hatamian H, Hoseini S, Nahayati MA, Nabavi SM, Faraji F, Harirchian MH, Mir NHN, Moghadam NB, Sharifipour E, Bayati A, Kamali H, Mozhdehipanah H, Jalali N, Abotorabi-Zarchi M, Kamyari N, Nikbakht R, Azimi A, Navardi S, Heidari H, Sahraian MA, Eskandarieh S. Khodaie F, et al. Among authors: navardi s. Clin Neurol Neurosurg. 2024 Apr;239:108221. doi: 10.1016/j.clineuro.2024.108221. Epub 2024 Mar 2. Clin Neurol Neurosurg. 2024. PMID: 38447483
Iranian specialists' approach to surgery in patients with multiple sclerosis.
Ghadiri F, Ebadi Z, Asadollahzadeh E, Sahraian MA, Azimi A, Navardi S, Heidari H, Abna Z, Aboutorabi M, Adibi I, Baghbanian SM, Paybast S, Poursadeghfard M, Hosseini S, Shahmohammadi S, Ghaffari M, Ghalyanchi-Langroodi H, Ghiasian M, Kamali H, Kouchaki E, Mahrabi F, Mohammadianinejad E, Nahayati MA, Moghadasi AN. Ghadiri F, et al. Among authors: navardi s. Curr J Neurol. 2023 Apr 4;22(2):96-102. doi: 10.18502/cjn.v22i2.13336. Curr J Neurol. 2023. PMID: 38011379 Free PMC article.
Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairment.
Ghadiri F, Asadollahzadeh E, Ebadi Z, Sahraian MA, Azimi A, Navardi S, Heidari H, Abna Z, Aboutorabi M, Adibi I, Baghbanian SM, Paybast S, Poursadeghfard M, Hosseini S, Shahmohammadi S, Ghaffari M, Ghalyanchi-Langroodi H, Ghiasian M, Kamali H, Kouchaki E, Mahrabi F, Mohammadianinejad E, Nahayati MA, Moghadasi AN. Ghadiri F, et al. Among authors: navardi s. Curr J Neurol. 2023 Jan 5;22(1):1-7. doi: 10.18502/cjn.v22i1.12610. Curr J Neurol. 2023. PMID: 38011357 Free PMC article.
Comparing infusion-related reactions of the first full dose (600 mg) biosimilar ocrelizumab administration with the standard divided protocol in multiple sclerosis patients: a randomized controlled trial study.
Abbasi Kasbi N, Ghadiri F, Sahraian MA, Nahayati MA, Moghadasi AN, Langroodi HG, Poursadeghfard M, Hosseini S, Heidari H, Baghbanian SM, Kamali H, Ameli Z, Shahmohammadi S, Navardi S. Abbasi Kasbi N, et al. Among authors: navardi s. Acta Neurol Belg. 2024 Feb;124(1):205-212. doi: 10.1007/s13760-023-02366-z. Epub 2023 Sep 15. Acta Neurol Belg. 2024. PMID: 37715074 Clinical Trial.
Investigation of the safety of live attenuated varicella-zoster virus vaccination in patients with relapse-remitting multiple sclerosis treated with natalizumab: A case series and review of the literature.
Paybast S, Sahraian MA, Nahayati MA, Habibi MA, Shahmohammadi S, Navardi S. Paybast S, et al. Among authors: navardi s. Mult Scler Relat Disord. 2023 Sep;77:104793. doi: 10.1016/j.msard.2023.104793. Epub 2023 Jun 2. Mult Scler Relat Disord. 2023. PMID: 37413854 Review.
Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics.
Ghadiri F, Sahraian MA, Razazian N, Ashtari F, Poursadeghfard M, Nabavi SM, Navardi S, Baghbanian SM, Shaygannejad V, Harirchian MH, Beladimoghadam N, Majdinasab N, Hosseini S, Azimi A, Kamali H, Sharifipour E, Hosseini Nejad Mir N, Bayati A, Nahayati MA, Heidari H, Mozhdehipanah H, Ghalyanchi Langroodi H, Jalali N, Ayoubi S, Asadollahzadeh E, Ebadi Z, Eskandarieh S, Naser Moghadasi A. Ghadiri F, et al. Among authors: navardi s. Mult Scler Relat Disord. 2023 Feb;70:104493. doi: 10.1016/j.msard.2022.104493. Epub 2022 Dec 29. Mult Scler Relat Disord. 2023. PMID: 36638768
Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years.
Ghadiri F, Sahraian MA, Baghbanian SM, Ashtari F, Razazian N, Majdinasab N, Poursadeghfard M, Hatamian H, Harirchian MH, Beladimoghadam N, Azimi A, Sharifipour E, Hosseini S, Bayati A, Kamali H, Hosseni Nejad Mir N, Faraji F, Mozhdehipanah H, Modara F, Navardi S, Heidari H, Ayoubi S, Naser Moghadasi A, Eskandarieh S. Ghadiri F, et al. Among authors: navardi s. Mult Scler Relat Disord. 2022 May;61:103777. doi: 10.1016/j.msard.2022.103777. Epub 2022 Mar 27. Mult Scler Relat Disord. 2022. PMID: 35390594
COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis.
Abbasi N, Ghadiri F, Moghadasi AN, Azimi A, Navardi S, Heidari H, Karaminia M, Sahraian MA. Abbasi N, et al. Among authors: navardi s. Mult Scler Relat Disord. 2022 Apr;60:103723. doi: 10.1016/j.msard.2022.103723. Epub 2022 Mar 5. Mult Scler Relat Disord. 2022. PMID: 35276452 Free PMC article.
19 results